# Drug Master Files for Bulk Antibiotic Drug Substances:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/drug-master-files-for-bulk-antibiotic-drug-substances-guidance-for-industry/2638fcb2-869c-4214-8f7d-6403c9f7b75e

> FDA guidance document: Drug Master Files for Bulk Antibiotic Drug Substances:  Guidance for Industry. Issue date: November 29, 1999. Get complete insights and analysis.

---

## Details

- Title: Drug Master Files for Bulk Antibiotic Drug Substances:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1999-11-29
- Last Changed: 2020-04-28
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-1314">FDA-1999-D-1314</a>

## Related Documents

- [Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1](https://www.globalkeysolutions.net/guidances/guidance-document/repeal-of-section-507-of-the-federal-food-drug-and-cosmetic-act-_1/2e6eed29-aedc-4122-900b-0eb9b1f9aaf0)
- [Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations](https://www.globalkeysolutions.net/guidances/guidance-document/extended-release-oral-dosage-forms-development-evaluation-and-application-of-in-vitroin-vivo-correlations/c2ea6b85-0c9d-4fc1-80f0-2b5b1c5dea0e)
- [Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/alternate-source-of-the-active-pharmaceutical-ingredient-in-pending-andas-guidance-for-industry/8a3da1bc-1ebb-48aa-a3ea-7662562c4370)